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Abstract
Barrett’s esophagus (BE) is an intestinal metaplasia that occurs in the setting of chronic acid and bile reflux and is associated
with a risk for adenocarcinoma. Expression of intestine-specific transcription factors in the esophagus likely contributes to
metaplasia development. Our objective was to explore the effects of an intestine-specific transcription factor when
expressed in the mouse esophageal epithelium. Transgenic mice were derived in which the transcription factor Cdx2 is
expressed in squamous epithelium using the murine Keratin-14 gene promoter. Effects of the transgene upon cell
proliferation and differentiation, gene expression, and barrier integrity were explored. K14-Cdx2 mice express the Cdx2
transgene in esophageal squamous tissues. Cdx2 expression was associated with reduced basal epithelial cell proliferation
and altered cell morphology. Ultrastructurally two changes were noted. Cdx2 expression was associated with dilated space
between the basal cells and diminished cell-cell adhesion caused by reduced Desmocollin-3 mRNA and protein expression.
This compromised epithelial barrier function, as the measured trans-epithelial electrical resistance (TEER) of the K14-Cdx2
epithelium was significantly reduced compared to controls (1189 Ohm*cm
2 6343.5 to 508 Ohm*cm
2692.48, p=0.0532).
Secondly, basal cells with features of a transitional cell type, intermediate between keratinocytes and columnar Barrett’s
epithelial cells, were observed. These cells had reduced keratin bundles and increased endoplasmic reticulum levels,
suggesting the adoption of secretory-cell features. Moreover, at the ultrastructural level they resembled ‘‘Distinctive’’ cells
associated with multilayered epithelium. Treatment of the K14-Cdx2 mice with 59-Azacytidine elicited expression of BE-
associated genes including Cdx1, Krt18, and Slc26a3/Dra, suggesting the phenotype could be advanced under certain
conditions. We conclude that ectopic Cdx2 expression in keratinocytes alters cell proliferation, barrier function, and
differentiation. These altered cells represent a transitional cell type between normal squamous and columnar BE cells. The
K14-Cdx2 mice represent a useful model to study progression from squamous epithelium to BE.
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Introduction
Barrett’s esophagus (BE) is a premalignant condition that
increases the risk for esophageal adenocarcinoma [1,2]. BE occurs
at the gastroesophageal junction and is the replacement of normal
squamous esophageal epithelium with an intestinalized columnar
epithelium. It arises in the setting of chronic acid and bile reflux
[3]. Despite its clinical importance, the molecular pathogenesis of
BE is poorly understood. One limitation in the study of BE
pathogenesis has been the lack of suitable experimental models.
Most commonly, investigators have relied upon human BE tissue
explants and esophageal adenocarcinoma cell lines for their studies
[4,5,6], or primary esophageal keratinocytes and BE cell lines
[7,8,9,10,11]. Current animal models require the surgical
placement of either an esophagogastroduodenostomy or an
esophagojejunostomy in rats and mice [12,13,14,15]. Reflux
esophagitis, metaplasia, and cancer have been described post-
operatively. However, the response of mice to the surgery has not
been as robust as with the rats [12].
An alternative approach is to utilize mouse genetics. This
method was successfully applied in modeling gastric intestinal
metaplasia [16,17]. Transgenic mice were derived in which the
Caudal-related transcription factor Cdx2 was ectopically expressed
in gastric epithelium. Cdx2 is a transcription factor known to
regulate intestine-specific gene expression, intestinal cell prolifer-
ation, and columnar shape, and is required for the normal
intestinal epithelium development [18,19,20,21,22,23,24,25,26].
Gastric expression of Cdx2 induced an intestinal metaplasia
consisting of goblet cells synthesizing intestinal mucins and
absorptive cells expressing alkaline phosphatase. CDX2 is
expected to play a similar role in the pathogenesis of BE [1,27].
CDX2 mRNA and protein are uniformly expressed in BE biopsy
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CDX2 expression can be detected in the esophagus prior to the
onset of BE, in the setting of chronic reflux esophagitis [28,29,30].
In vitro studies support this finding. Cdx2 expression can be
induced in primary cultures of esophageal keratinocytes treated
with short pulses of acid and bile [6,31]. In the present study we
demonstrate the effect that this ectopic Cdx2 expression can have
upon squamous epithelium.
Using the Keratin-14 gene promoter, we induce Cdx2 mRNA
and protein expression in the basal cell layer of squamous
epithelium. Cdx2 expression had significant effects upon cell
proliferation, cell-cell adhesion, and basal cell morphology. Most
significantly, Cdx2 expression promoted the adoption of a
secretory-cell ultrastructure with increased endoplasmic reticulum
levels and ER-associated proteins. These cells appear to represent
an intermediate stage of differentiation between keratinocytes and
columnar BE cells. Lastly, treatment of the K14-Cdx2 mice, but not
controls, with DNA methyltransferase inhibitors lead to the
expression of intestine- and BE-associated genes. We conclude
that the K14-Cdx2 mice represent an interesting mouse genetic
model of early events in BE pathogenesis. Ectopic Cdx2 expression
in the esophagus can initiate cellular changes consistent with an
intermediate stage between normal squamous epithelium and an
intestinalized, secretory epithelium similar to normal intestine and
BE. Moreover, advancement to a more intestinalized metaplasia in
the K14-Cdx2 mouse depends on changes in epigenetic gene
regulation in the esophagus.
Results
The Keratin-14 gene promoter directs expression of Cdx2
mRNA and protein to basal keratinocytes of squamous
epithelium
Ectopic expression of Cdx2 using the FoxA3 or the H
+/K
+-
ATPase gene promoters was sufficient to induce a gastric intestinal
metaplasia in transgenic mice [16,17,32]. To determine if a
similar approach would yield a novel model for Barrett’s
esophagus, we subcloned a murine Cdx2 cDNA into a well-
established K14/hGH transgenic expression vector (kindly
provided by Elaine Fuchs, Rockefeller University) (Figure 1A)
[33]. This vector reliably directs transgene expression to the basal
keratinocytes of the squamous epithelium including the skin,
tongue, esophagus, and forestomach. We established 7 transgenic
lines bearing the K14-Cdx2 vector. Two of the seven expressed
transgene mRNA detected by quantitative PCR analysis, but only
one line expressed Cdx2 protein observable by immunohisto-
chemistry and Western blot analysis of nuclear extracts (Figure 1
and data not shown).
In the K14-Cdx2 mice, ectopic Cdx2 expression was detected in
the skin as well as the esophagus and forestomach (Figure 1C and
D and Figure S1A and B). The level of Cdx2 expression in the
esophagus was about 10% of that observed in the intestine, and
the expression in the forestomach was even less, based on western
blot comparison of whole-cell lysates from these epithelia and the
liver as a negative control (Figure 1D). As expected based on
previous experience with this K14 promoter construct [34], we
observed Cdx2 protein expression predominantly in the nuclei of
basal cells, with weaker expression in suprabasal cells (Figure 1E).
As the squamous epithelium stem cells are reported to reside in
this same basal cell layer [35], we stained by immunofluorescence
for p63, a marker for these stem cells. Serial sections of esophageal
tissue stained for Cdx2 or p63 suggest there is an overlap in their
expression and therefore that the transgene Cdx2 is expressed in
p63+ esophageal stem-cells (Figure 1F).
Ectopic Cdx2 expression in esophageal keratinocytes
significantly reduces cell proliferation
Previous in vitro studies by us using a human esophageal
keratinocyte cell line found that Cdx2 expression significantly
reduced human keratinocyte cell proliferation [11]. Similarly, the
Cdx2 transgene appeared to significantly diminish BrdU incorpo-
ration by proliferating keratinocytes in vivo (Figure 2A and 2B).
BrdU incorporation rates per basal cell were half that of wild-type
(wt) littermates. Apoptotic rates were not noticeably altered by the
transgene (Figure S1C and 1D). Despite the measured difference
in proliferation rates, we were able to establish ex-vivo cultures of
esophageal keratinocytes from both wild-type and transgenic mice
(Figure 2C). Expression of the transgenic Cdx2 protein is
maintained in the K14-Cdx2 cells even after several cell passages
(Figure 2C, Inset). Consistent with the in vivo findings, the
proliferation rate for the cultured transgenic keratinocytes was
reduced by a third compared to wild-type control cells (Figure 2D).
This suggests that diminished proliferation of the K14-Cdx2
keratinocytes is largely due to effects upon the keratinocytes, since
the reduction is maintained when cells are cultured under identical
conditions ex vivo.
Figure 1. Generation of K14-Cdx2 mice and pattern of transgene
expression. A Schematic map of the transgene. B. PCR detection of
the transgene in genomic DNA. C+: positive control, C-; negative
control, M:s i z em a r k e r s .C. Transgene expression by reverse-
transcriptase PCR in RNA from esophagus (E) and Skin (S). D. Western
blot for Cdx2 expression in whole cell lysates from small intestine (SI),
liver (L), forestomach (FS), and the esophagus (E). Tubulin served as
loading control. E. Immunohistochemical staining for Cdx2 expression
in wild-type and transgenic esophagi. F. Immunofluorescence for Cdx2
(Red), p63 (Green), and DAPI (blue) in adjacent serial sections from
transgenic esophagi.
doi:10.1371/journal.pone.0018280.g001
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ultrastructure in the esophagus and forestomach
Examinations of the esophagus at three months revealed no
obvious defects in tissue architecture of the K14-Cdx2 mice
(Figure 3A). Despite the reduced cell proliferation, K14-Cdx2
epithelium appeared to be of normal thickness with a differenti-
ated and cornified superficial layer. However, on higher power
examination, we noted subtle changes in cell morphology of the
basal cell layer. Nuclei of the K14-Cdx2 basal keratinocytes
appeared to be elongated and the cells more densely packed and
disorganized than in the wild-type epithelium (Figure 3B).
To better appreciate these morphological changes, we exam-
ined the tissue ultrastructure by transmission electron microscopy
(TEM). Esophagi from 3 month old K14-Cdx2 transgenic and wild-
type control littermates were excised, fixed, and examined by
TEM. We noted a number of changes in our transgenic mouse
esophageal basal cells when compared to controls. In the controls,
basal keratinocytes appeared rectangular to cuboidal, with dark
cytoplasms full of electron-dense keratin bundles (Figure 3C). Basal
cells appeared to be strongly adherent with adjacent cells, as
evidenced by the many desmosomal junctions and little unfilled
space between cells.
In contrast, transgenic mouse basal cells were very different.
Basal cells with electron-dense cytoplasm and keratin bundles
Figure 2. Cdx2 expression reduces cell proliferation of murine
keratinocytes in vitro and in vivo. 3-month-old transgenic and wild-
type littermates were injected intraperitoneally with BrdU 1 hour prior
to sacrifice. A. Immunohistochemistry with Anti-BrdU antibody (US
Biological) shows reduction in proliferating cell numbers in transgenic
mice when compared with controls. B. Quantification of epithelial
proliferation based on BrdU incorporation in the esophagus. BrdU
positive cells per 150 basal epithelial cells were counted in four 3-
month old K14-Cdx2 mice and four matched littermate controls (n=4).
Blue Bar: Wild-type mice. Red bar: K14-Cdx2 transgenic mice. C.
Phase-contrast images of primary esophageal keratinocyte cell cultures
established from transgenic and wild-type littermate mice shows similar
morphology. Inset: Western blot for Cdx2 expression in nuclear lysates
from primary cultured keratinocytes from K14-Cdx2 and wild-type mice.
alpha-tubulin served as loading control. D. Cells were incubated with
BrdU for 1 hour, then fixed and imaged for BrdU incorporation with
DAPI counterstain. BrdU+ cells were counted in at least 100 total cells
from 3 different primary transgenic cell lines and three littermate
control lines. (n=3).
doi:10.1371/journal.pone.0018280.g002
Figure 3. Transgene expression alters basal epithelial cell
morphology and ultrastructure. A. Hematoxylin and eosin (H&E)
staining of 3 month-old wild-type and transgenic esophagi tissue at
low-power. B. Higher-powered images of serially-sectioned tissues
stained either with H&E or with the Cdx2 antibody. Basal cell layer
changes in cell morphology, in particular crowded, elongated nuclei
can be observed. C–D. Transmission-electron microscopy (TEM) images
of wild-type and transgenic esophageal tissue. BM=basement
membrane.
doi:10.1371/journal.pone.0018280.g003
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the epithelium had the appearance of pseudo-stratification, with
many cells in the suprabasal region extending long cellular
processes to the basal lamina (Figure 3D). The purpose of these
long processes was unclear, but their presence suggests cells
reluctant to disengage from the basement membrane as would be
normal for upward-migrating keratinocytes.
Cell-cell adhesive junctions appeared weakened. There were
fewer desmosomes visible in the transgenic basal layer compared
to controls. Moreover, there was more unfilled space between
basal cells of the transgenic mouse (Figures 3C, 3D, 4A, and 4B).
This increased intercellular space is reminiscent of the TEM
phenomena Dilated Intercellular Spaces (DIS). DIS has been
associated with acid reflux disease in humans and rabbit
esophageal mucosa after experimental acid exposure [36,37]. In
addition, DIS has been associated with diminished barrier function
in esophageal epithelium [38].
To quantify the DIS induced by Cdx2 expression, we used
IPLab image processing software to map and measure areas of
reduced density around cells. For this analysis, a single basal
keratinocyte, including cell-cell junctions (but not cell-basement
membrane junction) was cut from the original image, and regions
of reduced density plotted and quantified by the software
(Figures 4C and 4D). Using this technique, the significant
difference in intercellular space between wild-type and transgenic
basal cells is plainly seen. While wild-type basal cells had small
Figure 4. Cdx2 expression is associated with dilated intercellular space between basal cells and diminished barrier function. TEM
images from A. wild-type and B. transgenic mice illustrating the increased space between basal keratinocytes. Inset: higher-powered image of
intercellular space. BM=basement membrane. C. and D. Example of DIS mapping by IPLab software. Areas of low-density in the cut-out TEM image
were identified, filled in with false color and quantified for wild-type (C.) and transgenic (D.) basal keratinocytes. E. Average intercellular empty space
per cell, in microns
2. Results are the combined measurements from two wild-type mice (5–6 cells/mouse, n=11) and four transgenic mice (5–10 cells/
mouse, n=26). p values determined by Student’s T test. F. Average of cell area for cells examined, and the ratio of intercellular area to cell area.
doi:10.1371/journal.pone.0018280.g004
Modeling Barrett’s Esophagus with Cdx2 Expression
PLoS ONE | www.plosone.org 4 April 2011 | Volume 6 | Issue 4 | e18280regions of open space between cells, and minimal variability
between individual basal cells, the K14-Cdx2 basal cells had much
more visible and variable areas of DIS. These areas were then
quantified and averaged over multiple cells from several different
animals. The average open space surrounding K14-Cdx2 kerati-
nocytes is 17-fold greater than that seen in wild-type cells
(Figure 4E). Even after taking into account that the K14-Cdx2
basal keratinocytes were, on average, slightly larger than wild-type
cells (Figure 4F), the difference between transgenic and wild-type
was still nearly 15-fold (Figure 4E). In summary, expression of
Cdx2 in basal keratinocytes of the esophagus and forestomach
alters cell morphology and leads to dilated intercellular spaces
reminiscent of acid injury.
Ectopic Cdx2 expression in basal keratinocytes reduces
Desmocollin 3 levels and epithelial barrier function
We expected that the molecular processes contributing to the
measurable increases in intercellular spaces might be due to
alterations in cell-cell adhesion proteins. E-cadherin, Claudin-1
and Claudin-5 mRNA levels appeared unchanged by the
transgene expression (Figure S2). Immunohistochemical staining
for E-cadherin suggested some reduction in E-cadherin protein
levels, but this reduction was patchy and did not appear to be
the primary cause for the diminished cell-cell adhesion (Figure
S2). We noticed there were fewer desmosomes in the basal layer
cells on the TEM images (Figure 3CD and data not shown).
Desmocollins (Dsc) are members of the cadherin superfamily of
proteins and are critical components of desmosomes [39]. Dsc3
is typically expressed in multilayered squamous epithelium in
the basal cell layer. Quantitative PCR analysis for the
expression of Desmocollins 3 was performed. Dsc3 mRNA
levels were significantly reduced, by about 75% compared to
controls (Figure 5A). Histolog i c a l l y ,w es e ee v i d e n c ef o ra
significant reduction in Dsc3 pr o t e i n sl e v e l sa sw e l l .D s c 3
protein is localized to primarily the basal cell layer of the
esophagus (Figure 5B). Levels of Dsc3 protein appear consid-
erably reduced in the K14-Cdx2 mice (Figure 5C). Since the
Dsc3 staining was somewhat diffuse by epifluorescence, we
reimaged the tissues by confocal microscopy. Dsc3 staining was
punctate rather than diffuse, as would be expected for
desmosomes. Moreover, we can again clearly see significant
reductions in Dsc3 proteins levels in the K14-Cdx2 mice
compared to littermate controls (Figure 5D and E).
In order to determine if this Cdx2-associated reduction in
Dsc3 levels, reduction in desmosome numbers, and increased in
intercellular space at the basal cell layer had any significant
functional implications for the epithelia, we measured trans-
epithelial electrical resistance (TEER) using a mini Ussing
chamber [38]. The mouse esophag u si ss m a l la n dd i dn o ty i e l d
t i s s u ew i t he n o u g ha r e at oc o v er the chamber’s opening. We
t h e r e f o r em a d et h em e a s u r e m e n ts using the squamous fore-
s t o m a c hw h i c h ,a sw eh a v ed e m onstrated, expresses the
transgene (Figure S1). We observed that TEER was significantly
reduced in the K14-Cdx2 mice when compared to littermate
controls, suggesting an impairment of epithelial barrier function
(Figure 5F). K14-Cdx2 mice electrical resistance in the fore-
stomach was less than half of wild-type controls. Together these
findings establish that expression of Cdx2 in squamous
epithelium diminishes cell-cell adhesion in the basal cell layer
and reduces the epithelial barrier function.
Figure 5. DSC3 levels are reduced in K14-Cdx2 mice and are associated with diminished trans-epithelial electrical resistance. A. DSC3
mRNA levels quantified by QPCR in K14-Cdx2 and wild-type (WT) mice. n=3 mice for each measurement. B. Epifluorescent staining for DSC3 (Red)i n
basal cells in the esophageal epithelium from wild-type mouse. Nuclei counterstained with DAPI. The image is a merge of the fluorescent channels
with a differential interference contrast (DIC) image of the tissue. C. Epiflourescent image of DSC3 (Red)i nK14-Cdx2 esophageal epithelium,
counterstained with DAPI and merged with DIC. D. and E. Confocal examination of DSC3 (Red) protein in wild-type (D) and K14-Cdx2 (E) esophageal
epithelium. F. Mean TEER (6SEM) for wild-type (n=18) and K14-Cdx2 (n=19) forestomach epithelium as determined using a mini-Ussing chamber.
Measurements were log-transformmed to achieve approximate normality, then a two-sample t-test was performed to determine statistical
significance of the difference.
doi:10.1371/journal.pone.0018280.g005
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in the K14-Cdx2 mice
Ultrastructural analysis revealed another feature in the K14-
Cdx2 mice. A subpopulation of cells was observed that were
different from the more traditional keratinocytes. These cells
demonstrated a lower electron density (appeared pale) compared
to adjacent keratinocyte cells. They were located along the basal
cell layer, and they remained associated with adjacent basal
epithelial cells through desmosomes, and with basal lamina
through hemidemosomes (Figure 6A and B). These cells displayed
a significant reduction of cytokeratin bundles and free ribosomes
in the cytoplasm compared to adjacent keratinocytes, explaining
their reduced electron density. More interestingly, they appeared
to be developing extensive intracellular membrane compartment
including Endoplasmic Reticulum (ER), Golgi apparatus, and
other membrane vesicles (Figure 6C and D). These features are
more consistent with glandular type epithelial cells with active
secretory functions and are not characteristic of keratinocytes.
They are reminiscent of the multilayered epithelium (MLE)
‘Distinctive’ cells based on this appearance [40,41,42].
To better establish whether these vesicles represented ER and/
or golgi structures, we stained for protein disulfide isomerase (ER)
and giantin (golgi). These proteins are specific for the ER and
golgi, respectively [43,44]. Giantin levels appeared to be
unchanged with Cdx2 expression in the esophagus (Figure S3).
However, protein disulfide isomerase levels appeared consider-
ably increased in the basal cell layer of the K14-Cdx2 mice
(Figure 6E and F). The staining pattern is heterogeneous,
consistent with the TEM observation of heterogeneity as well.
Little protein disulfide isomerase is detected in wild-type basal
cells. Upper, differentiated layers appear to stain as well as the
transgenic mice, but it is not clear if this is due to non-specific
interactions of the antibody with the keratinizing cells. By
confocal microscopy we observe clear perinuclear staining in the
K14-Ccdx2 basal keratinocytes, as would be expected for an ER
protein (Figure 6F). Together these findings suggest Cdx2
expression is associated with significant alterations in basal
keratinocyte ultrastructure and cell identity.
Cdx2 synergizes with DNA methyltransferase inhibitor to
induce Barrett’s esophagus and intestinal genes
While ectopic expression of Cdx2 had several significant effects
on keratinocyte cell biology and appears to have induced a cell
lineage with increased secretory ultrastructure, there was no
significant induction of intestinal or Cdx2-target genes. Alcian blue
staining for mucin-producing cells was negative, as was qPCR and
immunohistochemical studies for Muc-2, Sucrase isomaltase,
Lactase phlorzin hydrolase, Carbonic anhydrase I, alkaline
phosphatase, Down-regulated in adenoma (S26A3/DRA), Na-H
Exchanger 2 (NHE2), and Guanyl Cyclase-C (data not shown).
Previously, we observed that Cdx2-expression in a human
esophageal keratinocyte cell line similarly failed to induce known
Cdx2 gene targets [11]. We found, however, that treatment of
these cells with 59-Azacytidine (5Aza), a DNA methyltransferase
inhibitor, lead to a Cdx2-specific induction of a number of
Barrett’s associated genes including SLC26A3/DRA, NHE2, and
Keratin-20. This suggested epigenetic mechanisms were involved
in the inhibition of Cdx2 gene targets in human esophageal
keratinocytes. To determine if the same process was silencing
Cdx2 target genes in the K14-Cdx2 mice, we treated the mice with
intraperitoneal (IP) injections of 5Aza (1mg/kg) three times a week
for two weeks (Figure 7A). The mice were then sacrificed, and
portions of their esophagi were fixed and embedded for histology,
and the remainder used for qPCR analysis. Histologic evaluation
of the esophagi from treated K14-Cdx2 and control mice revealed
no obvious changes in tissue morphology (data not shown).
However, qPCR studies revealed several significant changes.
Cdx2 mRNA levels were increased by 10-fold in wild-type mice,
and 250-fold in K14-Cdx2 mice treated with 5Aza (Figure 7B). Of
greater interest, mRNA levels from the Cdx2 homologue, Cdx1,
were significantly increased, but only in treated K14-Cdx2 mice
(Figure 7C). Similarly, SLC26A3/DRA and Keratin-18 (Krt18)
levels were significantly increased, but only in K14-Cdx2 mice
treated with 5Aza (Figure 7C). All three genes are known to be
ectopically expressed in Barrett’s esophagus along with Cdx2, and
both Cdx1 and SLC26A3/DRA are known Cdx2 gene targets
[10,11]. The increased mRNA expression resulted in detectable
Cdx1 and Krt18 protein by immunohistochemistry in the K14-
Cdx2 mice treated with 5Aza but not similarly treated wild-type
mice (Figure 7D and E). Several other genes, including p16, CAI,
Figure 6. Transgene expression is associated with adoption of
a more glandular ultrastructure. A. TEM of basal keratinocyte from
wild-type mouse demonstrating keratin bundles in cytoplasm. KB=ker-
atin bundle; BM=basement membrane. B. TEM of four ‘‘pale’’ basal
cells in K14-Cdx2 mice. C. TEM of another cluster of pale cells
demonstrating increased numbers of cytoplasmic vesicles suggestive
of a glandular or secretory cell ultrastructure. Inset: magnified vesicle.
D. TEM of another set of secretory-type cells in the basal layer with
prominent golgi. Inset: magnified golgi. E. and F. Levels and
distribution of the endoplasmic reticulum marker protein disulfide
isomerase are visualized with the Red channel by Epifluorescent (E)
and confocal (F) microscopy. The tissue was counterstained with DAPI.
BM= basement membrane.
doi:10.1371/journal.pone.0018280.g006
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in the K14-Cdx2 or control mice (data not shown). We conclude
that K14-Cdx2 mice can be induced to express more Cdx2 gene
targets and BE-associated gene markers if chromatin remodeling
and/or epigenetic DNA changes can be elicited.
Discussion
Barrett’s esophagus is the replacement of squamous epithelium
in the esophagus with a columnar epithelium expressing intestinal
features. BE itself is asymptomatic [1]. However, BE has also been
identified as a predisposing lesion for the development of
esophageal adenocarcinoma [1,2], and therefore remains a
clinically important condition. Our studies elucidate the conse-
quences of ectopic Cdx2 expression in esophageal epithelium, and
models an intermediate stage in the emergence of an intestinalized
epithelium from normal squamous epithelium.
Ectopic Cdx2 expression in the esophagus is associated
with significant changes in epithelial function
Expression of Cdx2 mRNA has been detected in esophageal
epithelium in gastroesophageal reflux patients in the absence of BE
[30], in the normal appearing squamous epithelium proximal to
established BE [45], and can be provoked in esophageal
keratinocytes in vitro when cultured under conditions of acidic
or bile acid stress [6,31]. The level of Cdx2 protein expressed
within these cells can vary. Nuclear-localized Cdx2 protein is
observed in columnar epithelium of BE and in the in vitro cultures
of acid-treated keratinocytes. There also appears to be a low-level
of Cdx2 protein localized in the cytoplasm of squamous epithelial
cells from GERD patients[30,46,47]. However the consequences
of this ectopic expression for epithelial integrity and cell biology
have not been explored.
Our findings in the K14-Cdx2 mouse establishes that this
expression is associated with two significant effects, reduced cell
proliferation, and diminished barrier function. The reduction in
cell proliferation is significant and correlates with our previously
published study using primary immortalized human esophageal
keratinocytes [11]. While this reduction was not associated with
any deleterious effects in the normal mouse, we anticipate that
under stress conditions, such as in the setting of GERD induced
injury, the ability of the epithelium to undergo repair and replace
dead cells may be significantly impacted. Studies are underway to
stress the epithelium of K14-Cdx2 mice by physiologic processes
that mimic reflux. We anticipate observing significant differences
when this epithelium is stressed compared to wild-type mice.
Moreover, the significantly dilated intercellular spaces (DIS) we
noted in the basal cell layer of the K14-Cdx2 mice are associated
with increased paracellular permeability in the esophagus and
forestomach, as demonstrated by the significantly reduced TEER.
This is consistent with published reports in which acid-provoked
DIS has been associated with diminished barrier function [38].
While the ultrastructure appearance resembles DIS associated
with acute acid injury in animal models [36], we do not suspect
acid is the cause of this DIS. Rather, the Cdx2 mediated reduction
cell-cell adhesion appears to be the critical event. E-cadherin
protein levels are somewhat disturbed, however E-cadherin,
Claudin-1, and Claudin-5 mRNA levels are entirely unaffected.
In contrast, Dsc3 mRNA and protein levels are both significantly
diminished, suggesting this may be the primary event, with effects
upon E-cadherin and other cell adhesion processes affected
secondarily. Disruption of desmosome formation may make all
cell-cell adhesive junctions less stable, leading to increased E-
cadherin turn-over and diminished protein levels. Future studies
will examine the molecular events leading to diminished Dsc3
gene expression in K14-Cdx2 mice. We conclude that ectopic cdx2
expression in basal esophageal keratinocytes significantly impacts
Figure 7. Treatment of K14-Cdx2 mice with DNA methyltrans-
ferase inhibitors induces Cdx2 targets and BE-associated
genes. A. 1mg/kg of 59-Azacytidine was injected intraperitoneally on
the indicated days (Blue arrow) and the mice were sacrificed on day 14
(Red arrow), 2 days after the last injection. B. qPCR measurements of
Cdx2 mRNA levels, n=6. WT=wild-type mice; X2=K14-Cdx2 mice. C.
Determination of Cdx1, Slc26a3/DRA, and KRT18 mRNA levels by qPCR,
n=6. D. Cdx1 protein by immunohistochemistry in treated wild-type
and K14-Cdx2 mice. E. Keratin-18 by immunohistochemical staining.
doi:10.1371/journal.pone.0018280.g007
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permeability.
A subpopulation of K14-Cdx2 esophageal epithelial cells
resembles a transitional cell type associated with
Barrett’s esophagus
The emergence of the specialized columnar epithelium
characteristic of BE within a stratified squamous epithelium has
been difficult to explain. Indeed, the identity of the progenitor cell
that gives rise to Barrett’s epithelium remains an open question
[48,49]. It is expected that the progression to BE is a stepwise
process, with intermediate stages in between. While no BE
precursor lesion is widely accepted, there has been emerging data
regarding an altered epithelium known as multilayered epithelium
(MLE) [50,51,52,53]. MLE is described as a hybrid epithelium,
with squamous cells in the basal portion and columnar cells
layered above, and is thought to represent a transitional stage or
intermediate cell type in the squamous to columnar conversion to
metaplasia in BE. Gene expression patterns are also hybrid in this
cell type, with both squamous cytokeratins (KRT4 and KRT13) and
columnar (KRT8 and KRT19) detected in the MLE.
At the ultrastructural level, MLE is marked by the presence of a
‘Distinctive cell’, characterized by microvilli (columnar cell feature)
and intercellular ridges (squamous cell feature). Distinctive cells
also possess abundant secretory-type intracellular vesicles (colum-
nar cell feature) [40,41,42]. Pathologically, MLE is usually
detected at or near the neo-squamocolumnar junction in BE,
and is strongly correlated with reflux. Rat surgical models of acid
and bile reflux similarly induce MLE [54,55,56]. Studies have
found Cdx2 expression in both human MLE [55] and the
surgically-provoked MLE in rats [56]. Based on these findings,
ectopic Cdx2 expression may contribute to the development of
MLE, a transitional cell type between squamous and columnar
cells in BE.
Thus, the ultrastructural findings of pale cells with abundant
cytoplasmic endoplasmic reticulum in the K14-Cdx2 mice were both
very novel and exciting. These cells resemble a transitional cell type
between keratinocytes and columnar secretory cells. Moreover, they
share many features of the ‘Distinctive cell’, except the K14-Cdx2
‘Distinctive cells’ are located in the basal cell compartment and do
not have visible microvilli. These findings are the first experimental
evidence to demonstrate that ectopic Cdx2 expression in keratino-
cytes generates cells with features of the ‘Distinctive cell in MLE’. It
is interesting to speculate whether the increased ER levels observed
in these ‘Distinctive’ cells provides them a protective advantage by
fostering quicker cell membrane repairs after acid and bileinjury, or
better control of intracellular pH when stressed by GERD.
Alternatively, with the reduced cell proliferation, cell-cell adhesion,
and barrier function, this intermediate cell stage may be unstable in
the setting of active reflux and likely to progress to a more complete
intestinal morphology and ultrastructure. This will be a focus for
future studies.
The absence of a mature BE columnar cell morphology in our
transgenic mice was not unexpected. Despite Cdx2’s required role
in intestinal epithelial development [20], as a single factor it does
not appear able to reprogram a cell once a developmental
program has been initiated. Timing of the expression appears to
be critical. Cdx2 disruption early in development leads to failure of
intestinal epithelial development and its replacement with a multi-
layered squamous epithelium due to an anterior homeotic identity
shift [20]. However, loss of Cdx2 after adoption of an intestinal
identity causes a disruption in cell differentiation and polarization,
but not the adoption of a squamous cell identity [57]. The K14
promoter is active in the esophagus early during development but
after the cells have adopted a keratinocyte identity[58]. We
selected this promoter, rather than one active earlier in
development, because we were trying to model the transition to
Barrett’s esophagus in adults rather than simply modulate
differentiation programs during development. The induction of
the endoplasmic reticulum-laden cells is a very strong indication
that the transition to a columnar-type metaplasia from a
keratinocyte is a possibility if the correct gene combinations and
cellular microenvironment can be induced.
One reason that developmental patterns are difficult to disrupt
once established is that chromatin remodeling usually occurs to
silence competingregions ofthe genome[59,60]. Therefore,ectopic
expression of critical transcription factors may not initiate new
developmental patterns unless chromatin remodeling occurs.
Moreover, there is evidence of significant differences in epigenetic
gene regulation between normal squamous epithelium and Barrett’s
esophagus [61,62,63,64]. Our use of 5-Aza was an attempt to open
these areas of silenced chromosomes to Cdx2 transcriptional
activity. Our induction of Cdx2 and Keratin18 protein in the
K14-Cdx2 mice by treatment with 59-Azacytidine supports this
hypothesis and serves as the basis for future studies. However, 59-
Azacytidine non-specifically demethylates DNA by inhibiting DNA
methyltransferase activity. This broad effect, in the absence of any
selective pressure (such as from acid and bile reflux), may be why we
observe some gene expression changes but no significant change in
epithelial cell morphology. Future experiments will try to induce a
GERD environment to provide selective pressure for the emergence
of a more Barrett’s like epithelium.
In summary, we establish the K14-Cdx2 mouse as a useful
animal model for studies of BE pathogenesis. Ectopic Cdx2
expression in the esophagus can reduce epithelial cell proliferation
and diminish the epithelial barrier function while inducing a
subpopulation of cells with diminished keratin bundles and
increased endoplasmic reticulum. Thus our findings suggest the
expression of a single transcription factor, Cdx2, is sufficient to
induce a population of cells in transition between squamous
keratinocytes and columnar BE cells. We anticipate these mice will
be useful in studies of BE pathogenesis as we employ a variety of
strategies to advance the metaplasia phenotype, and test whether
these transitional cells have acquired any advantage to respond to
GERD conditions. These are important avenues we plan to
explore in future studies.
Materials and Methods
Generation of K14-Cdx2 transgenic mice
All studies with the mouse models was fully approved by the
Institutional Animal Care and Use Committee (IACUC) at the
University of Pennsylvania (IACUC#525400). The University of
Pennsylvania is fully accredited by the American Association for
Accreditation of Laboratory Animal Care, and the animal care
and use program conforms to all required standards. A cDNA
comprising the coding region of murine Cdx2 (1035 bp) was
inserted into the Bam HI site of the K14/hGH expression vector
(a kind gift of Elaine Fuchs, The Rockefeller University, New
York, New York) [33]. This Keratin 14 (K14) promoter is active in
the basal layer of the squamous epithelium for the esophagus,
tongue, oral mucosa, and skin. The resulting plasmid was digested
with EcoRI and used for microinjection of fertilized ova of FVB/N
mice (Taconic, Germantown, NY). Transgenic founders were
identified by polymerase chain reaction (PCR) and confirmed by
southern blot analysis and bred to establish lines. All PCR primers
listed in Table S1. Transgenic founders of the BGSJL/F1 strain
(Jackson Laboratory, Bar Harbor, ME) were bred with normal
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Wilmington, MA) for 3 generations. All animals were bred under
pathogen-free conditions and used for experiments at 6–12 wk of
age. All experiments with mice were conducted with the approval
and in compliance with the guidelines of The Institutional Animal
Care and Use Committee (IACUC) of the University of
Pennsylvania School of Medicine.
Isolation and culturing of primary mouse esophageal
keratinocytes
Esophagi were isolated from young mice (1–3 months), opened
longitudinally, washed in PBS, and incubated with 0.6–1.0 U/ml
of Dispase 1 (Roche Applied Science, Mannheim, Germany) for
15 minutes at 37uC, and epithelial sheets were stripped from
mesenchymal tissues using forceps [65]. The epithelial sheets were
minced and incubated with 0.05% trypsin/EDTA (Gibco) for 10
minutes at 37uC. The trypsin was then quenched with 200 mg/ml
soybean trypsin inhibitor (Sigma-Aldrich, St Louis, MO) and the
suspension passed through a 40-mm cell strainer (Becton
Dickinson). Cells were centrifuged and resuspended in keratino-
cyte serum-free medium (KSFM; Gibco) with EGF (1 ng/ml),
BPE (50 mg/ml).
Western Blot Analysis
Total proteins were isolated from the esophageal epithelium of
3-month old mice by an adaptation of a previously described
method [66]. Frozen esophageal tissue was thawed and homog-
enized using a Potter-Elvehjem homogenizer at 4uC in the
presence of Complete Protease Inhibitor Cocktail (Boehringer
Mannheim, Indianapolis, IN). Protein concentration was deter-
mined by the BCA protein assay (Pierce, Rockford, IL). Western
blot analysis was then conducted. The blot was incubated with
monoclonal Cdx2 antibody (clone CDX2-88) (1:1000; BioGenex,
San Ramon, CA), and then visualized with secondary anti-mouse
horseradish peroxidase-conjugated antibodies and chemilumines-
cence detection (ECL; Milipore). To verify equal loading of
samples, the blots were stripped and reprobed with anti-tublin
(Sigma, St Louis, MO) at 1:1500.
Quantitative Reverse Transcription-Polymerase Chain
Reaction
Samples were stored in tissue storage reagent (RNAlater;
Ambion, Austin, TX). Total RNA was isolated using RNeasy
Mini kit (Qiagen, Valencia, CA). cDNA was prepared from total
RNA using the SuperScriptH VILO
TM cDNA Synthesis Kit
(Invitrogen, Carlsbad, CA). Primers were designed using Primer
Express software (Applied Biosystems). All PCR primers are listed
in Table S1. Taqman primers for Desmocollin 3, villin, DRA,
NHE2, which were obtained from Applied Biosystems (Foster
City, CA). Quantitative RT-PCR was performed on an ABI 7000
sequence detection system (Applied Biosystems, Foster City, CA),
with SYBR green or Taqman as the fluorescent dye using
standard PCR conditions. A dissociation curve was run with each
PCR as a control. A ribosomal phosphoprotein, 36B4, was used as
the normalization control. DC
t values were calculated after
duplicate PCRs for each sample as described, [22,67] then
statistical analysis performed. DDC
t values were then calculated
and used to determine fold-change in expression.
Transepithelial electrical resistance (TEER)
Mouse forestomachs were excised and placed in buffer
containing in mM: 120 NaCl, 25 NaHCO3, 3.3 KH2PO4, 0.8
K2HPO4, 1.2 MgCl2, 1.2 CaCl2, and 10 glucose. Forestomachs
were individually pinned across a 0.3 cm
2 opening in a specialized
slider (P2304, Physiologic Instruments, San Diego, CA) for
insertion into a vertical Ussing chamber (Physiologic Instruments).
Mucosal and serosal baths were the same buffer in which tissue
was stored following excision. While in the Ussing chamber, tissues
were kept at 37uC and the solutions were constantly mixed by gas
lift with 95% O2/5% CO2 such that solution pH was kept between
7.35 and 7.45. Tissues were voltage-clamped continuously to 0mV
after fluid resistance compensation using an automatic voltage
clamp (VCC 600, Physiologic Instruments). Short-circuit current
(ISC) was digitized at 1 sample every 10 seconds, and data were
stored on a computer hard drive using Acquire and Analyze
software build 2.3.0 (Physiologic Instruments). Transepithelial
resistance (RT) was determined automatically by the software using
a protocol for stepping the clamp potential from 0 mV to +/2
10 mV for 240 ms every minute, recording the change in ISC, and
calculating RT from Ohm’s law (RT = DV/DI). The average RT
over 2 m was taken as the tissue resistance.
Immunohistochemical and Immunofluorescence
analyses
All specimens were isolated, rinsed in ice-cold PBS, fixed, and
analyzed histologically by staining sections with hematoxylin and
eosin (H&E) or immunohistochemically using standard methods as
described [68]. Five-mm paraffin-embedded sections were pre-
treated with xylene and then placed in a microwave oven in
10 mmol/L citric acid buffer. Endogenous peroxidases were
quenched using hydrogen peroxide before sections were incubated
in avidin D blocking reagent and biotin blocking reagent. Primary
antibodies used include monoclonal Cdx2 (1:200, Biogenex, San
Ramon, CA), p63 (1:500, gift of Makoto Senoo, University of
Pennsylvania, Philadelphia, PA), Cdx1 CPSP (1:750) [35], ER
marker PDI (1:1,000, Cell Signaling Technology #3501, Beverly,
MA) and for proliferation using bromodeoxyuridine (BrdU)
antibody (1:1,500, Upstate, Charlottesville, VA). Sections were
incubated with primary and biotinylated secondary antibodies and
an avidin-horseradish peroxidase conjugate (Vectastain Elite ABC
kit; Vector Laboratories, Burlingame, CA) following the manu-
facturer’s protocol. The signal was developed using the 3,39-
diaminobenzidine substrate kit (Vector Laboratories). Sections
were counterstained with hematoxylin. The serial sections were
stained for Cdx2 and p63 by immunofluorescence using antibodies
listed in Table S2.
For Alcian blue staining, slides were deparaffinized. After
application of 3% aqueous acetic acid to the slides, 1% Alcian blue
in 3% acetic acid, pH 2.5, was applied. Sections were washed and
counterstained with 0.1% nuclear fast red, dehydrated, and
mounted. For immunofluorescence detection of Golgi marker on
the esophageal reconstructs, frozen tissue sections were fixed with
4% Paraformaldehyde for 3-5 minutes and blocked with Protein
Blocking Agent (StartingBlockTM T20Blocking Buffer Thermo
Scientific #37539) at room temperature for 10 minutes. Primary
anti-Giantin (ab24586, Abcam, Cambridge, MA, US) antibody at
a concentration of 1:1,000 were incubated overnight at 4uC. Slides
were washed with PBS four times, and secondary anti-rabbit
antibody was incubated at 37uC for 30 minutes. After incubation,
slides were washed with PBS four times, counterstained with
DAPI, and then photographed under a Nikon E600 fluorescent
microscope and confocal microscope.
BrdU labeling/Proliferation Studies
BrdU incorporation rate was measured in the basal layer of
transgenic and non-transgenic littermate controls. Mice were
injected with BrdU (Zymed) at 1.0 mg/ml 1 hour before
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and fixed in 4% PFA. Esophageal tissues from WT mice were used
as controls. After BrdU immunohistochemistry, BrdU-labeled
nuclei were counted in the basal layer from regions of the
esophagus. Positive cells were expressed as the number of BrdU(+)
cells per crypt unit. Three transgenic and matched nontransgenic
littermates control mice from each of the three K14-Cdx2 lines
were measured in this study. Ten random visual fields were
analyzed per esophageal section, and percent BrdU–positive cells
was determined using IPLab Software (Scanalitics, Fairfax, VA).
At least 500 cells were measured in each mouse. IP Lab was used
to quantitate cell staining of BrdU.
Transmission Electron Microscopy (TEM) ultra-structural
analysis
For TEM, tissues were fixed and analyzed as described
previously described [22]. For transmission electron microscopy
(TEM), tissues were fixed in 2.5% (w/v) glutaraldehyde and 2.0%
paraformaldehyde in 0.1 M cacodylate buffer (pH 7.4) at 4uC
overnight. After buffer wash, the samples were post-fixed in 2%
osmium tetroxide for 1 h, washed again in buffer, and dehydrated
in a graded ethanol series. Samples were treated with several
changes of hexamethyldisilazane (HMDS) and then allowed to air
dry prior to mounting and sputter-coating with gold. TEM
examinations were made, and three to five TEM photos/per
animal were taken with a Philips XL20 TEM microscope.
The quantitation of intercellular space between basal layer cells
of the esophageal epithelium was measured using IPLab software
(Scanalytics, Fairfax, VA). Intercellular spaces were delineated in
between 5–10 epithelial cells from the basal layer of each mouse.
Two wild-type and four transgenic mice were used in these studies.
The region to be analyzed was outlined manually. It included the
cell and the cell membranes from all adjacent cells, but not the
bottom of the cell where it attaches to the basement membrane.
The software then identified low-density pixels, outlined contig-
uous ones, and computed their total area. Then the cell area not
including the DIS was outlined manually and the total cell area
computed. For statistical analysis, all cell data were combined and
DIS, cell area, and DIS/cell area averaged across control and
transgenic mice.
Statistics
All data is expressed as mean 6 Standard deviation unless
indicated. Single comparisons were performed by Student’s t-test
when appropriate. The distribution of trans-epithelial electrical
resistance (TEER) in both the wild-type and K14-Cdx2 mice
groups was right-skewed. Hence a log-transformation was used to
achieve approximate normality (Shapiro Wilk test for normality p-
value=0.8557 for K14-Cdx2 and 0.5098 for wild-type mice). A
two-sample t-test on the log transformed resistance measurements
was performed to determine statistical significance of the
difference (t=2.00, df=35, p-value=0.0532).
Supporting Information
Figure S1 Cdx2 expression in K14-Cdx2 forestomach
and TUNEL assays. Immunohistochemistry for A. Cdx2 in
squamous forestomach from K14-Cdx2 mice. B. Anti-mouse
secondary Ab staining controls for Cdx2 immunohistchemistry.
C. TUNEL staining for apoptotic cells in Wild-type littermate
esophagus. D. TUNEL staining for apoptotic cells in K14-Cdx2
mouse esophagus.
Found at: doi: (TIF)
Figure S2 Quantitative PCR for cell-cell adhesion
proteins in K14-Cdx2 mice. A. mRNA levels for E-cadherin
by qPCR in 3 month old K14-Cdx2 and control littermate mice;
n=5; p values determined by Student’s T test. Immunohisto-
chemistry for E-cadherin in the esophagi from 3 month old B.
control littermate mice or C. K14-Cdx2 mice. mRNA levels for D.
Claudin-1, and E. Claudin-5 by qPCR.
Found at: doi: (TIF)
Figure S3 Levels and distribution of the golgi protein
Giantin are unchanged by the Cdx2 transgene. The levels
and distribution of the golgi protein Giantin (Red) are visualized
by epifluorescent microscopy in esophageal epithelium from A.
Wild-type (WT) and B. K14-Cdx2 transgenic mice. Nuclei were
counterstained with DAPI (Blue). BM= basement membrane.
Higher power, confocal microscopy evaluation for Giantin levels
and distribution in C. Wild-type and B. K14-Cdx2 mice.
Found at: doi: (TIF)
Table S1 Antibodies used in this study.
Found at: doi: (DOC)
Table S2 qPCR Primers used in this study.
Found at: doi: (DOC)
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